MarketWatchBusiness9 Nov 2026, 15:16 UKA failed trial for a heart drug casts shadow over rivals developing similar therapiesThe full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.Read original reporting ↗